Efficient synthesis of glycosylated phenazine natural products and analogs with DISAL (methyl 3,5-dinitrosalicylate) glycosyl donors

Organic and Biomolecular Chemistry

Volumn 1, Issue 18, 2003, Pages 3147-3153

  Laursen, Jane B ^a,b   Petersen, Lars ^b   Jensen, Knud J ^a   Nielsen, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CATALYST SELECTIVITY; ENZYME INHIBITION; GLUCOSE;

GLYCOSYLATION;

BIOCHEMISTRY;

3,5 DINITROSALICYLIC ACID; 3,5-DINITROSALICYLIC ACID; PHENAZINE DERIVATIVE; SALICYLIC ACID DERIVATIVE; SAPHENAMYCIN;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; ORGANIC CHEMISTRY; STREPTOMYCES; SYNTHESIS;

CHEMISTRY, ORGANIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSYLATION; MODELS, CHEMICAL; PHENAZINES; SALICYLIC ACIDS; STREPTOMYCES;

EID: 0141860915     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b306789k     Document Type: Article

References (36)

1. D. J. Faulkner, Nat. Prod. Rep., 1991, 8(2), 97-147.
2. K. H. Michel, M. M. Hoehn, US Pat., 4316959, 1982 (Chem. Abstr. 1982, 96, 197888)
3. K. H. Michel, M. M. Hoehn, US Pat., 4316959, 1982 (Chem. Abstr. 1982, 96, 197888)
4. W. Keller-Schierlein, A. Geiger, H. Zähner and M. Brandl, Helv. Chim. Acta, 1988, 71, 2058-2070
5. A. Geiger, W. Keller-Schierlein, M. Brandl and H. Zähner, J. Antibiot., 1988, 41, 1542-1551
6. M. Kitahara, H. Nakamura, Y. Matsuda, M. Hamada, K. Meada, H. Umezawa and Y. Iitaka, J. Antibiot., 1982, 35, 1412-1414.
7. B.-S. Yun, I.-J. Ryoo, W.-G. Kim, J.-P. Kim, H. Koshino, H. Seto and I.-D. Yoo, Tetrahedron Lett., 1996, 37, 8529-8530.
8. L. Petersen, K. J. Jensen and J. Nielsen, Synthesis, 1999, 10, 1763-1766.
9. J. B. Laursen, C. G. Jørgensen and J. Nielsen, Bioorg. Med. Chem., 2003, 11(5), 723-731.
10. J. B. Laursen, P. de Visser, H. K. Nielsen, K. J. Jensen and J. Nielsen, Bioorg. Med. Chem. Lett., 2002, 12, 171-175.
11. U. Hollstein and R. J. Van Gemert, Jr., Biochemistry, 1971, 10, 497-504
12. C. W. Mosher, D.-Y. Lee, R. M. Enanoza, P. A. Sturm and K. F. Kuhlmann, J. Med. Chem., 1979, 22, 918-922.
13. J. R. Kerr, Infect. Dis. Rev., 2000, 2(4), 184-194.
14. S. A. Gamage, J. A. Spicer, G. J. Finlay, A. J. Stewart, P. Charlton, B. C. Baguley and W. A. Denny, J. Med. Chem., 2001, 44, 1407-1415
15. J. A. Spicer, S. A. Gamage, G. J. Finlay and W. A. Denny, Bioorg. Med. Chem., 2002, 10, 19-29.
16. M. Ge, Z. Chen, H. R. Onishi, J. Kohler, L. L. Silver, R. Kerns, S. Fukuzawa, C. Thompson and D. Kahne, Science, 1999, 284, 507-511
17. K. C. Nicolaou, H. J. Mitchell, F. L. van Delft, F. Rübsam and R. M. Rodgríguez, Angew. Chem., Int. Ed., 1998, 37, 1871-1874.
18. F. Arcamone, Doxorubicin; Anticancer Antibiotics, Academic Press, New York, 1981
19. S. Penco and F. Arcamone, Molecular aspects of anticancer drug action, ed. J. W. Lown, Macmillan Press, London, 1988
20. R. D. Andersen, M. L. Veigl, J. Baxter and W. D. Sedwick, Cancer Res., 1991, 51, 3930-3937.
21. D. B. Berkowitz, S. Choi, D. Bhuniya and R. K. Shoemaker, Org. Lett., 2000, 2(8), 1149-1152.
22. S. Erbeck, X. Liang, D. Hunkler, R. Krieger and H. Prinzbach, Eur. J. Org. Chem., 1998, 1925-1948.
23. C. Pathirana, P. R. Jensen, R. Dwight and W. Fenical. J. Org. Chem., 1992, 57, 740-742.
24. L. Petersen and K. J. Jensen, J. Org. Chem., 2001, 66, 6268-6275
25. L. Petersen and K. J. Jensen, J. Chem. Soc., Perkin Trans. 1, 2001, 2175-2182
26. J. B. Laursen, L. Petersen and K. J. Jensen, Org. Lett., 2001, 3, 687-690
27. L. Petersen, J. B. Laursen, K. Larsen, M. S. Motawia and K. J. Jensen, Org. Lett., 2003, 5(8), 1309-1312.
28. For a review of glycosylation protocols under neutral or mild basic conditions, see: K. J. Jensen, J. Chem. Soc., Perkin Trans. 1, 2002, 20, 2219-2233.
29. For a review of combinatorial synthesis of natural products, see: J. Nielsen, Curr. Opin. Chem. Biol., 2002, 6(3), 297-305.
30. 3 or AcOH, rt, 24 h) leads to complete decomposition of the phenazine structure.
31. K. Ley and F. Seng, Synthesis. 1975, 415-422
32. D. L. Vivian, J. Am. Chem. Soc., 1951, 73, 457-458.
33. B. Capon and S. P. McManus, Neighbouring Group Participation, PlenumPress, New York, 1976.
34. The compounds were screened in growth inhibition studies by LEO Pharma A/S on a panel of Gram-positive skin flora (Micrococcus luteus, Propionibacterium acnes, Streptococcus pyogenes, Staphylococcus epidermidis, Staphylococcus aureus) and on two resistant Staphylococcus aureus strains: clinical isolates of fusidic acid resistant and rifampicin resistant MRSA.
35. S. W. Langer, G. Schmidt, M. Sørensen, M. Sehested and P. B. Jensen, Clin. Cancer Res., 1999, 5, 2899-2907
36. B. B. Hasinoff, T. I. Kuschak, J. C. Yalowich and A. M. Creighton, Biochem. Pharmacol., 1995, 50(7), 953-958.